Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 67184-0623

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 67184-0623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure of doxorubicin hydrochloride, showing its characteristic multi-ring anthracycline structure with attached sugar moiety and hydrochloride salt.*

FDA Label Image

Mpeg-dspe Structural Formula (Image 02)

Chemical structure diagram showing a complex molecule consistent with a liposomal formulation component, featuring repeated ethylene glycol units, phosphate groups, and long lipid chains, indicating a lipid-polymer conjugate typical in liposomal drug delivery systems.*

FDA Label Image

Hspc Structural Formula (Image 03)

Chemical structure diagram of doxorubicin hydrochloride showing its molecular components and arrangement, including phosphate and lipid chains indicated by variables m and n representing chain lengths of 14 or 16 carbons.*

FDA Label Image

Representation Of A Pegylated Liposome (Image 04)

An illustration showing the structural components of a liposomal formulation. It highlights the PEG2-DSPE coating on the exterior, an aqueous core containing entrapped doxorubicin hydrochloride, and a liposomal bilayer membrane.*

FDA Label Image

Figure 1 (Image 05)

A Kaplan-Meier survival curve showing percent of subjects progression-free over time (months) comparing two groups: one treated with Doxorubicin Hydrochloride plus Bortezomib and the other with Bortezomib alone. The graph includes censored data points and reports a significant p-value (<0.0001) with hazard ratio (HR) and confidence interval (CI). A table beneath shows the number of subjects at risk over time for each treatment group.*

FDA Label Image

Representative 20 mg Container Label (Image 06)

Label for Doxorubicin Hydrochloride Liposome Injection, 20 mg in 10 mL (2 mg/mL) single-dose vial. The product is a liposomal formulation indicated for intravenous infusion after dilution. The label includes storage instructions to refrigerate at 2° to 8°C (36° to 46°F) and warnings against freezing and substitution. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd., China. Cytotoxic and Rx only.*

FDA Label Image

Representative 20 mg Carton Label (Image 07)

Packaging label for doxorubicin hydrochloride liposome injection, 2 mg/mL, in a 10 mL single-dose vial. The label includes the proprietary name, dosage form as liposomal injection for intravenous infusion, storage instructions, and a warning not to substitute the formulation. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. The label also displays a barcode and detailed ingredient and excipient information for the liposomal formulation.*

FDA Label Image

Representative 50 mg Container Label (Image 08)

Label for doxorubicin hydrochloride liposome injection, 50 mg in 25 mL (2 mg/mL) single-dose vial. The label specifies it is for intravenous infusion only after dilution and for prescription use only. It warns not to substitute for doxorubicin hydrochloride, noting its liposomal formulation and cytotoxic nature. The product is manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. with storage instructions to refrigerate at 2° to 8°C and not freeze. A barcode is visible on the right side.*

FDA Label Image

Representative 50 mg Carton Label (Image 09)

Packaging label for Doxorubicin Hydrochloride Liposome Injection 2 mg/mL by Qilu Pharmaceutical Co., Ltd. The label indicates a 50 mg in 25 mL (2 mg/mL) single-dose vial, liposomal formulation for intravenous infusion after dilution. Includes storage instructions, cytotoxic warning, barcode, and detailed composition information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.